-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UxCISwqpG+VeRHlTtY/TADg81OK0lh3+WGPPtBvkE7w6/PPDOnAjiXhwXsYeu1id D9gK6uSRtXYtXmeJVwM30Q== 0001022079-06-000079.txt : 20060705 0001022079-06-000079.hdr.sgml : 20060704 20060705163731 ACCESSION NUMBER: 0001022079-06-000079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060701 FILED AS OF DATE: 20060705 DATE AS OF CHANGE: 20060705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07608 BUSINESS PHONE: 2013935000 MAIL ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PFEIFFER GARY M CENTRAL INDEX KEY: 0001127304 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 06944716 BUSINESS ADDRESS: BUSINESS PHONE: 3027733854 MAIL ADDRESS: STREET 1: 1007 MARKET ST CITY: WILMINGTON STATE: DE ZIP: 19898 4 1 doc.xml PRIMARY DOCUMENT X0202 4 2006-07-01 0001022079 QUEST DIAGNOSTICS INC DGX 0001127304 PFEIFFER GARY M C/O QUEST DIAGNOSTICS INCORPORATED 1290 WALL STREET WEST LYNDHURST NJ 07071 1 0 0 0 Common Stock 3334 D Phantom Stock 0 2006-07-01 4 A 0 408.88 0 A Common Stock 408.88 1876.54 D Expiration date is not applicable since this is not a stock option. The total reflected in this column is inaccurate due to a computer program error. Reporting Person has accrued a total of 2,872.43 Phantom Stock Units to date in his Deferred Compensation Account, including phantom stock units credited during the prior quarter as a result of unreported dividend reinvestment transactions. Exercise date is not appplicable as this is not a stock option. The Phantom Stock units were accrued on a periodic basis under the Quest Diagnostics Incorporated Deferred Compensation Plan and are to be settled in cash based on the then fair market value of the Company's Common Stock upon the Reporting Person's retirement. Reporting Person's current term expires in May 2008 (the next annual meeting of shareholders of the Company). The information was obtained from the plan administrator as of the current date. Leo C. Farrenkopf, Jr., atty-in-fact for Gary M. Pfeiffer 2006-07-05 -----END PRIVACY-ENHANCED MESSAGE-----